한국형 우울장애 약물치료 알고리듬 2017(II) : 정신병적 양상을 동반한 우울장애Korean Medication Algorithm for Depressive Disorder 2017(II) : Psychotic Depression
- Authors
- 왕희령; 우영섭; 서정석; 박영민; 김원; 정종현; 심세훈; 이정구; 홍진표; 전덕인; 민경준; 박원명
- Issue Date
- 2017
- Publisher
- 대한우울∙조울병학회
- Keywords
- 주요우울장애; 정신병적 양상; 약물치료; 알고리듬; Psychotic depression; Korean medication algorithm for depressive disorder 2017; Major depression; Pharmacotherapy
- Citation
- 우울조울병, v.15, no.1, pp 14 - 20
- Pages
- 7
- Journal Title
- 우울조울병
- Volume
- 15
- Number
- 1
- Start Page
- 14
- End Page
- 20
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/5919
- ISSN
- 1738-0960
2671-4655
- Abstract
- Objectives : The Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) was developed to revise the previous version, the Korean Medication Algorithm Project for Depressive Disorder 2012 (KMAP-DD 2012), to reflect accumulated new findings regarding pharmacotherapy for depression. Methods : A total of 144 psychiatrists with numerous clinical experiences and academic achievements in treating depression were selected. The KMAP-DD 2017 survey was sent to them through e-mail. Of these, 79 answered the survey. The survey consists of seven parts and 44 questions. Each treatment strategy was categorized into three recommendation classifications ; first-line, second-line, and third-line, based on a 95% confidence interval. Results : For psychotic depression, an antidepressant augmented with atypical antipsychotics was selected as the first-line initial treatment. In case of an inadequate treatment response after the first treatment step, switching to another antidepressant, switching to another atypical antipsychotic agent, and adding another antidepressant were selected as first-line treatments.
In case of an inadequate treatment response at the second treatment step, switching to another antidepressant, switching to another atypical antipsychotic agent, and adding another antidepressant were selected as first-line treatment options for third step treatment. Conclusion : The KMAP-DD 2017 is expected to provide useful guidance for treating psychotic depression, based on expert consensus and formulated recommendations, enabling clinicians to effectively choose treatment options in clinical practice.
Objectives : The Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) was developed to revise the previous version, the Korean Medication Algorithm Project for Depressive Disorder 2012 (KMAP-DD 2012), to reflect accumulated new findings regarding pharmacotherapy for depression. Methods : A total of 144 psychiatrists with numerous clinical experiences and academic achievements in treating depression were selected. The KMAP-DD 2017 survey was sent to them through e-mail. Of these, 79 answered the survey. The survey consists of seven parts and 44 questions. Each treatment strategy was categorized into three recommendation classifications ; first-line, second-line, and third-line, based on a 95% confidence interval. Results : For psychotic depression, an antidepressant augmented with atypical antipsychotics was selected as the first-line initial treatment. In case of an inadequate treatment response after the first treatment step, switching to another antidepressant, switching to another atypical antipsychotic agent, and adding another antidepressant were selected as first-line treatments.
In case of an inadequate treatment response at the second treatment step, switching to another antidepressant, switching to another atypical antipsychotic agent, and adding another antidepressant were selected as first-line treatment options for third step treatment. Conclusion : The KMAP-DD 2017 is expected to provide useful guidance for treating psychotic depression, based on expert consensus and formulated recommendations, enabling clinicians to effectively choose treatment options in clinical practice.
- Files in This Item
-
Go to Link
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/5919)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.